Exchange Traded Concepts, LLC Neogenomics Inc Transaction History

Exchange Traded Concepts, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$7.06 - $13.97 $740,403 - $1.47 Million	-104,873 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$12.15 - $35.28 $98,828 - $286,967	-8,134 Reduced 7.2%	104,873 $1.27 Million
Q4 2021 Jan 13, 2022	BUY	$30.49 - $48.49 $685,140 - $1.09 Million	22,471 Added 24.82%	113,007 $3.86 Million
Q3 2021 Oct 18, 2021	BUY	$41.66 - $52.52 $745,880 - $940,318	17,904 Added 24.65%	90,536 $4.37 Million
Q2 2021 Jul 30, 2021	BUY	$36.62 - $51.69 $359,461 - $507,389	9,816 Added 15.63%	72,632 $3.28 Million
Q1 2021 Apr 20, 2021	BUY	$41.56 - $59.88 $1.23 Million - $1.77 Million	29,497 Added 88.53%	62,816 $3.03 Million
Q4 2020 Jan 19, 2021	BUY	$36.08 - $56.47 $576,630 - $902,503	15,982 Added 92.18%	33,319 $1.79 Million
Q3 2020 Oct 30, 2020	BUY	$33.26 - $40.48 $159,182 - $193,737	4,786 Added 38.13%	17,337 $640,000
Q2 2020 Jul 15, 2020	BUY	$24.21 - $31.02 $180,800 - $231,657	7,468 Added 146.92%	12,551 $389,000
Q1 2020 Apr 14, 2020	BUY	$20.5 - $34.53 $36,736 - $61,877	1,792 Added 54.45%	5,083 $140,000
Q4 2019 Jan 22, 2020	BUY	$18.96 - $29.84 $62,397 - $98,203	3,291 New	3,291 $96,000

292

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.87B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.